Inventor
LIDDLE JOHN
GB33 patents
⚠️ This page may combine multiple inventors who share the name “LIDDLE JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GLAXO GROUP LTD
13 patentsUS7919492B2Apr 5, 2011
Compounds
GLAXO GROUP LTD13 citations92
US7550462B2Jun 23, 2009
Piperazinediones as oxytocin receptor antagonists
GLAXO GROUP LTD15 citations92
US9452169B2Sep 27, 2016
Substituted diketopiperazines and their use as oxytocin antagonists
GLAXO GROUP LTD4 citations84
US9408851B2Aug 9, 2016
Compounds
GLAXO GROUP LTD6 citations84
US8937179B2Jan 20, 2015
Substituted diketopiperazines and their use as oxytocin antagonists
GLAXO GROUP LTD7 citations84
US8742099B2Jun 3, 2014
Compounds
GLAXO GROUP LTD7 citations84
US8357685B2Jan 22, 2013
Substituted diketopiperazines and their use as oxytocin antagonists
GLAXO GROUP LTD8 citations84
US8541579B2Sep 24, 2013
Substituted diketopiperazines as oxytocin antagonists
GLAXO GROUP LTD6 citations82
US8367673B2Feb 5, 2013
Substituted diketopiperazines as oxytocin antagonists
GLAXO GROUP LTD8 citations82
US10039755B2Aug 7, 2018
2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors
GLAXO GROUP LTD2 citations71
US9833449B2Dec 5, 2017
2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors
GLAXO GROUP LTD2 citations71
US9518054B2Dec 13, 2016
2-(azaindol-2-yl) benz imidazoles as PAD4 inhibitors
GLAXO GROUP LTD2 citations60
US9447074B2Sep 20, 2016
Compounds
GLAXO GROUP LTD0 citations50
GLAXOSMITHKLINE IP DEV LTD
6 patentsUS10246447B2Apr 2, 2019
3-(6-chloro-3-oxo-3,4-dihydro-(2H)-1,4-benzoxazin-4-yl) propanoic acid derivatives and their use as KMO inhibitors
GLAXOSMITHKLINE IP DEV LTD2 citations72
US9932328B2Apr 3, 2018
3-(6-alkoxy-5-chlorobenzo[d]isoxazol-3-yl)propanoic acid useful as kynurenine monooxygenase inhibitors
GLAXOSMITHKLINE IP DEV LTD2 citations72
US10611756B2Apr 7, 2020
Method of treating pancreatitis using 1,4-benzoxazine derivatives
GLAXOSMITHKLINE IP DEV LTD0 citations51
US10273232B2Apr 30, 2019
3-(6-alkoxy-5-chlorobenzo[D]isoxazol-3-YL)propanoic acid useful as kynurenine monooxygenase inhibitors
GLAXOSMITHKLINE IP DEV LTD0 citations51
US10815218B2Oct 27, 2020
Benzoimidazole derivatives as PAD4 inhibitors
GLAXOSMITHKLINE IP DEV LTD0 citations49
US10407407B2Sep 10, 2019
Benzoimidazole derivatives as PAD4 inhibitors
GLAXOSMITHKLINE IP DEV LTD0 citations49
SMITHKLINE BEECHAM CORP
3 patentsUS7514437B2Apr 7, 2009
Substituted diketopiperazines as oxytocin antagonists
SMITHKLINE BEECHAM CORP15 citations90
US7297792B2Nov 20, 2007
Pyrazolopyridines and pyrazolopyridazines as antidiabetics
SMITHKLINE BEECHAM CORP6 citations70
US7109199B2Sep 19, 2006
Pyrazolopyridines and pyrazolopyridazines as antidiabetics
SMITHKLINE BEECHAM CORP4 citations59